Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively

Clinical trial NCT02305888 · COMPLETED

Trial details

NCT number: NCT02305888
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2015-03-01
Primary completion: 2015-07-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.